Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ASA Gold and Precious Metals Ltd C.ASA


Primary Symbol: ASA

ASA Gold and Precious Metals Limited is a non-diversified, closed-end investment company. The Company's investment objective is long-term capital appreciation primarily through investing in companies engaged in the exploration for, development of projects or mining of precious metals and minerals. The Company invests approximately 80% of its total assets in common shares or securities convertible into common shares of companies engaged, directly or indirectly, in the exploration, mining or processing of gold, silver, platinum, diamonds or other precious minerals; held as bullion or other direct forms of gold, silver, platinum or other precious minerals; in instruments representing interests in gold, silver, platinum or other precious minerals, and/or in securities of investment companies, including exchange traded funds, or other securities. The Company’s investment adviser is Merk Investments LLC.


NYSE:ASA - Post by User

Post by AbrahamSTon Feb 15, 2019 9:24am
137 Views
Post# 29369661

January Newsletter - VGW

January Newsletter - VGW
 
January in Review

Valens ("The Company") (CSE:VGW) (OTC:VGWCF) is pleased to provide the following update on operations:

Multiple Service Agreements Signed
In pushing towards Valens' commitment of being best-in-class for cannabis extraction, testing and analytics, the Company signed two new significant extraction service agreements with reputable producers in Canada.

  • The first agreement is with Sundial Growers. This agreement is a multi-year agreement where Sundial will send bulk dried cannabis to Valens to be processed on a fee for service basis into crude, distillate or other cannabis oil derivatives as desired by Sundial. 
  • The second agreement is with New Brunswick-based, Organigram. This agreement is a multi-year agreement where the Company will extract cannabis flowers and trim from Organigram’s Moncton operation as well as hemp to produce extract concentrate.


Corporate Developments
The Company is extremely pleased to have welcomed leading fund manager, Everett Knight, to the executive team as Executive Vice President of Strategy and Investments. Everett brings a wealth of experience in portfolio management and industry experience as his previous endeavors included analyzing hundreds of companies in the space. 

Valens announced a strategic secondary purchase and sale transaction on January 30th. The transaction included a total of 3,500,000 shares at a price $2.05 per share between strategic purchasers (the “Buyers”) and 1009638 B.C. Ltd. (the “Seller”). The Buyers are independent in nature as they are not directly associated with a third party licensed producer. On close of the transaction the Seller hereby represents that it continues to be a significant shareholder of the Company and has opted to lock-up the remaining shares they hold in Valens for 6 months showing its long term commitment to the Company. The Buyers will also lock-up shares for a period of 4 months on close of the transaction. AltaCorp Capital Inc. has acted as agent in the transaction.

Leading Fund Manager Joins Valens Executive Team

Initiating Coverage Reports
AltaCorp Capital published an initiating coverage report on Valens this month that included a buy recommendation, a target price of $5.00 and stating the Company is one of the "premier business' in the industry. “We also view Valens as amongst the most undervalued businesses in the cannabis sector, offering investors with extremely favourable gross margins,” they added while forecasting the company would generate “significant free cash flows” on an annual basis. 

 

 
 
Valens in the News
AltaCorp Capital Discusses Valens' Potential on Midas Letter Live

The Value of R&D in the Cannabis Industry

Cannabis Companies Seeing Huge Opportunity in New Wave of CBD Processing and Production

 
 
 
 
Copyright © 2018 Valens Groworks Corp., All rights re

<< Previous
Bullboard Posts
Next >>